Transforming Growth Factor Beta Signaling in Hepatocytes Participates in Steatohepatitis Through Regulation of Cell Death and Lipid Metabolism in Mice

Cited by (281)

Items 101–200 of 281

  1. Anti-miR-96 and Hh pathway inhibitor MDB5 synergistically ameliorate alcohol-associated liver injury in mice
    Virender Kumar, Bharti Sethi, Dalton W. Staller, Xiaofei Xin, Jingyi Ma, Yuxiang Dong, Geoffrey A. Talmon, Ram I. Mahato · 2023 · Biomaterials
  2. Clusterin deficiency induces lipid accumulation and tissue damage in kidney
    Jung-Yoon Heo, Ji-Eun Kim, Yongwook Dan, Yong‐Woon Kim, Jong‐Yeon Kim, Kyu Hyang Cho, Young Kyung Bae, Seung‐Soon Im, Kwang‐Hyeon Liu, In‐Hwan Song et al. · 2018 · Journal of Endocrinology
  3. A Cross Talk Between BRG1 and Males Absent on the First Contributes to Reactive Oxygen Species Production in a Mouse Model of Nonalcoholic Steatohepatitis
    Li Liu, Wenxuan Hong, Min Li, Haozhen Ren, Jinglin Wang, Huihui Xu, Xiaolei Shi, Yong Xu · 2018 · Antioxidants and Redox Signaling
  4. 3D human nonalcoholic hepatic steatosis and fibrosis models
    Sushila Maharjan, Diana Bonilla, Princy Sindurakar, Hongbin Li, Wanlu Li, Sérgio M. Duarte, Ali Zarrinpar, Yu Shrike Zhang · 2021 · Bio-Design and Manufacturing
  5. Programmed increases in LXRα induced by paternal alcohol use enhance offspring metabolic adaptation to high-fat diet induced obesity
    Richard Cheng-An Chang, Kara N. Thomas, Yudhishtar S. Bedi, Michael C. Golding · 2019 · Molecular Metabolism
  6. Resveratrol Alleviates Liver Fibrosis Induced by Long-Term Inorganic Mercury Exposure through Activating the Sirt1/PGC-1α Signaling Pathway
    Siyu Li, Biqi Han, Jiayi Li, Zhanjun Lv, Huijie Jiang, Yunfeng Liu, Xu Yang, Jingjing Lu, Zhigang Zhang · 2024 · Journal of Agricultural and Food Chemistry
  7. Molecular Pathways Modulated by Mesenchymal Stromal Cells and Their Extracellular Vesicles in Experimental Models of Liver Fibrosis
    Giulia Chiabotto, Chiara Pasquino, Giovanni Camussi, Stefania Bruno · 2020 · Frontiers in Cell and Developmental Biology
  8. Progression of diet induced nonalcoholic steatohepatitis is accompanied by increased expression of kruppel-like-factor 10 in mice
    Ja Kyung Kim, Kwan Sik Lee, Hye Young Chang, Woon Kyu Lee, Jung Il Lee · 2014 · Journal of Translational Medicine
  9. Construction and analysis of protein-protein interaction network of non-alcoholic fatty liver disease
    Athina I. Amanatidou, George V. Dedoussis · 2021 · Computers in Biology and Medicine
  10. Comparison of hepatic gene expression profiles between three mouse models of Nonalcoholic Fatty Liver Disease
    Liping Xiang, Yang Jiao, Yiling Qian, Yao Li, Fei Mao, Yan Lü · 2021 · Genes & Diseases
  11. Liposomal Silybin Improves Glucose and Lipid Metabolisms in Type 2 Diabetes Mellitus Complicated with Non-Alcoholic Fatty Liver Disease via AMPK/TGF-β1/Smad Signaling
    Jialuo Cai, Yilin Zhu, Xiaoping Li, Guiming Deng, Yuanshan Han, Feiyun Yuan, Gang-Qiang Yi, Xinhua Xia · 2023 · The Tohoku Journal of Experimental Medicine
  12. Conophylline inhibits non-alcoholic steatohepatitis in mice
    Yukiomi Nakade, Kazumasa Sakamoto, Taeko Yamauchi, Tadahisa Inoue, Yuji Kobayashi, Takaya Yamamoto, Norimitsu Ishii, Tomohiko Ohashi, Yoshio Sumida, Kiyoaki Ito et al. · 2017 · PLoS ONE
  13. Protective role of magnesium isoglycyrrhizinate in non-alcoholic fatty liver disease and the associated molecular mechanisms
    QIAN XU, Ji Wang, Feifei Chen, Kaisu Lin, Mingao Zhu, LEI CHEN, Xiumin Zhou, Chong Li, Hong Zhu · 2016 · International Journal of Molecular Medicine
  14. Advanced oxidation protein products induce hepatocyte epithelial–mesenchymal transition via a ROS‐dependent, TGF‐β/Smad signaling pathway
    Shibo Sun, Fang Xie, Qifan Zhang, Zhonglin Cui, Xinsheng Cheng, Feng Zhong, Kun He, Jie Zhou · 2017 · Cell Biology International
  15. Rodent models of fatty liver diseases
    Adeline Bertola · 2018 · Liver Research
  16. Pharmaceutical Efficacy of Gypenoside LXXV on Non-Alcoholic Steatohepatitis (NASH)
    Jin Ha Lee, Ji Young Oh, Soo Hyun Kim, In Jeong Oh, Yong‐ho Lee, Keun Woo Lee, Woong Hee Lee, Jeong‐Hwan Kim · 2020 · Biomolecules
  17. Hepatocyte-specific Prominin-1 protects against liver injury-induced fibrosis by stabilizing SMAD7
    Hyun Lee, Dongmin Yu, Myeong‐Suk Bahn, Young-Jae Kwon, Min Jee Um, Seo Yeon Yoon, Ki‐Tae Kim, Myoungwoo Lee, Sung-Je Jo, Sungsoo Lee et al. · 2022 · Experimental & Molecular Medicine
  18. The potential of mecciRNA in hepatic stellate cell to regulate progression of nonalcoholic hepatitis
    Boqiang Liu, Yuanshi Tian, Jing He, Qiuxia Gu, Binghan Jin, Hao Shen, Weiqi Li, Liang Shi, Hong Yu, Ge Shan et al. · 2022 · Journal of Translational Medicine
  19. Ablation of the deubiquitinase USP15 ameliorates nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
    Jung-Hwan Baek, Myung Sup Kim, Hye Ryeon Jung, Min-Seon Hwang, Chan-Ho Lee, Dai Hoon Han, Yong‐ho Lee, Eugene C. Yi, Seung‐Soon Im, Ilseon Hwang et al. · 2023 · Experimental & Molecular Medicine
  20. Dendrimer-conjugated podophyllotoxin suppresses DENA-induced HCC progression by modulation of inflammatory and fibrogenic factors
    Supriya Sharma, Mehak Mehak, Jyoti Chhimwal, Vikram Patial, Ugir Hossain Sk · 2019 · Toxicology Research
  21. miR-181a promotes porcine granulosa cell apoptosis by targeting TGFBR1 via the activin signaling pathway
    Jiaqing Zhang, Binwen Gao, Hongxia Guo, Qiaoling Ren, Xianwei Wang, Junfeng Chen, Jing Wang, Zijing Zhang, Qiang Ma, Baosong Xing · 2019 · Molecular and Cellular Endocrinology
  22. Intercellular communication among liver cells in the perisinusoidal space of the injured liver: Pathophysiology and therapeutic directions
    Devaraj Ezhilarasan, Mustapha Najimi · 2022 · Journal of Cellular Physiology
  23. Investigating fibrosis and inflammation in an ex vivo NASH murine model
    Emilia Gore, Emilia Bigaeva, Anouk Oldenburger, Yvette J. M. Jansen, Detlef Schuppan, Miriam Boersema, Jörg F. Rippmann, Andre Broermann, Peter Olinga · 2020 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  24. IL‑6 inhibitors effectively reverse post‑infarction cardiac injury and ischemic myocardial remodeling via the TGF‑β1/Smad3 signaling pathway
    Jiahong Wang, Minghong Wang, Xiancheng Lu, Yi Zhang, Siliang Zeng, Xin Pan, Yimeng Zhou, Hui Wang, Nannan Chen, Fengfeng Cai et al. · 2022 · Experimental and Therapeutic Medicine
  25. Attenuating the rate of total body fat accumulation and alleviating liver damage by oral administration of vitamin D-enriched edible mushrooms in a diet-induced obesity murine model is mediated by an anti-inflammatory paradigm shift
    Ariel Drori, Dory Rotnemer-Golinkin, Sharon Avni, Ariel Drori, Ofer Danay, D. Levanon, Joseph Tam, L. Zolotarev, Yaron Ilan · 2017 · BMC Gastroenterology
  26. Dual signaling pathways of TGF-β superfamily cytokines in hepatocytes: balancing liver homeostasis and disease progression
    Roohi Chaudhary, Ralf Weiskirchen, Marcelo Ehrlich, Yoav I. Henis · 2025 · Frontiers in Pharmacology
  27. Hepatoprotection of Probiotics Against Non-Alcoholic Fatty Liver Disease in vivo: A Systematic Review
    Faezah Sabirin, Siong Meng Lim, Chin Fen Neoh, Kalavathy Ramasamy · 2022 · Frontiers in Nutrition
  28. Deletion of Smad4 reduces hepatic inflammation and fibrogenesis during nonalcoholic steatohepatitis progression
    Geng Qin, Guo Zhen Wang, Dan Guo, Ru Bai, Miao Wang, Shi Du · 2018 · Journal of Digestive Diseases
  29. Emerging role of adipokine apelin in hepatic remodelling and initiation of carcinogensis in chronic hepatitis C patients.
    Rola M Farid, Riham Mohamed Abu-Zeid, Ahmed El-Tawil · 2014 · PubMed Central
  30. Aldehydes alter TGF-β signaling and induce obesity and cancer
    Xiaochun Yang, Krishanu Bhowmick, Shuyun Rao, Xiyan Xiang, Kazufumi Ohshiro, RICHARD L. AMDUR, Md. Imtaiyaz Hassan, Taj Mohammad, Keith A. Crandall, Paolo Cifani et al. · 2024 · Cell Reports
  31. The Role of Clinical Proteomics, Lipidomics, and Genomics in the Diagnosis of Alzheimer’s Disease
    Ian James Martins · 2016 · Proteomes
  32. Effect of Adrenergic Agonists on High-Fat Diet-Induced Hepatic Steatosis in Mice
    Yukiomi Nakade, Rena Kitano, Taeko Yamauchi, Satoshi Kimoto, Kazumasa Sakamoto, Tadahisa Inoue, Yuji Kobayashi, Tomohiko Ohashi, Yoshio Sumida, Kiyoaki Ito et al. · 2020 · International Journal of Molecular Sciences
  33. Association between cardiometabolic index and all-cause and cause-specific mortality among the general population: NHANES 1999–2018
    Mingjie Liu, Chendong Wang, Rundong Liu, Yan Wang, Bai Wei · 2024 · Lipids in Health and Disease
  34. The mitochondrial NAD kinase functions as a major metabolic regulator upon increased energy demand
    Hyunbae Kim, Zhiyao Fu, Zhao Yang, Zhenfeng Song, El Hussain Shamsa, Thangal Yumnamcha, Shengyi Sun, Wanqing Liu, Ahmed S. Ibrahim, Nathan Qi et al. · 2022 · Molecular Metabolism
  35. Mapping Proteome and Lipidome Changes in Early-Onset Non-Alcoholic Fatty Liver Disease Using Hepatic 3D Spheroids
    Helle Sedighi Frandsen, Joel Mario Vej-Nielsen, Lauren Elizabeth Smith, Lang Sun, Karoline Lindgaard Mikkelsen, Annemette Præstegaard Thulesen, Christina E. Hagensen, Fuquan Yang, Adelina Rogowska-Wrzesińska · 2022 · Cells
  36. Ethanol Enhances TGF‐β Activity by Recruiting TGF‐β Receptors From Intracellular Vesicles/Lipid Rafts/Caveolae to Non‐Lipid Raft Microdomains
    Shuan Shian Huang, Chun‐Lin Chen, Franklin W. Huang, Frank E. Johnson, Jung San Huang · 2015 · Journal of Cellular Biochemistry
  37. Serum Fetuin-A Associated With Fatty Liver Index, Early Indicator of Nonalcoholic Fatty Liver Disease
    Ya Fang Huang, Xiaolin Huang, Lin Ding, Wang Po, Kui Peng, Ying Chen, Meng Dai, Di Zhang, Min Xu, Yufang Bi et al. · 2015 · Medicine
  38. Oxidized corn oil changes the liver lipid metabolism of broilers by upregulating peroxisome proliferators activate receptor-α
    Yu‐Qing Zhang, Tahir Mahmood, Yuqin Wu, Zhenhai Tang, Youli Wang, Wei Wu, Huajin Zhou, Yuming Guo, Jianmin Yuan · 2022 · Poultry Science
  39. High-fat and high-carbohydrate diets increase bone fragility through TGF-β–dependent control of osteocyte function
    Neha S. Dole, Andrés Betancourt-Torres, Serra Kaya, Yoshihiro Obata, Charles A. Schurman, Jihee Yoon, Cristal S. Yee, Vivek Khanal, Clarissa Aguirre Luna, Madeline D. Carroll et al. · 2024 · JCI Insight
  40. Hepatocellular Interactions of Potential Nutraceuticals in the Management of Inflammatory NAFLD
    Devaraj Ezhilarasan, Langeswaran Kulanthaivel · 2024 · Cell Biochemistry and Function
  41. Ameliorative potential of omega 3 fatty acids and HMG-CoA reductase inhibitors on experimentally-induced non-alcoholic steatohepatitis
    Ahmed M. Kabel, Maaly A. Abd Elmaaboud, Ahmed A. Albarraq · 2014 · Prostaglandins Leukotrienes and Essential Fatty Acids
  42. GP73, a novel TGF-β target gene, provides selective regulation on Smad and non-Smad signaling pathways
    Xiaoli Yang, Congwen Wei, Ning Liu, Feixiang Wu, Jian‐Kang Chen, Cui Wang, Zhen-Yu Jim Sun, Yufei Wang, Liping Liu, Xiaoli Zhang et al. · 2019 · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
  43. In Vitro Production of Human Ballooned Hepatocytes in a Cell Sheet-based Three-dimensional Model
    Botao Gao, Katsuhisa Sakaguchi, Katsuhisa Matsuura, Tetsuya Ogawa, Y. Kagawa, Hirotsugu Kubo, Tatsuya Shimizu · 2019 · Tissue Engineering Part A
  44. Caveolin-1 Impacts on TGF-β Regulation of Metabolic Gene Signatures in Hepatocytes
    Mei Han, Zeribe C. Nwosu, Weronika Piorońska, Matthias Ebert, Steven Dooley, Christoph Meyer · 2020 · Frontiers in Physiology
  45. l -Carnitine-induced amelioration of HFD-induced hepatic dysfunction is accompanied by a reduction in hepatic TNF-α and TGF-β1
    Mabrouk Attia Abd Eldaim, Fatma Mohamed Ibrahim, Sahar Hassan Orabi, Azza Mohammed Hassan, Hesham Saad El Sabagh · 2018 · Biochemistry and Cell Biology
  46. Doxycycline hyclate: A schistosomicidal agent in vitro with immunomodulatory potential on granulomatous inflammation in vivo
    Miriam Viviane Dias, Aline Pereira Castro, Camila Cabral Campos, Thaiany Goulart de Souza e Silva, Reggiani Vilela Gonçalves, Raquel Lopes Martins Souza, Marcos José Marques, Rômulo Dias Novaes · 2019 · International Immunopharmacology
  47. Loss of EGFR contributes to high‐fat diet‐induced nonalcoholic fatty liver disease
    Fang Shao, Hao Deng, Wei Zhang, Zhengrong Ren, Zhiqian Kang, Zhi Ding, Junfeng Zhang, Yuhui Zang · 2023 · FEBS Letters
  48. Comprehensive Strategy for Identifying Extracellular Vesicle Surface Proteins as Biomarkers for Non-Alcoholic Fatty Liver Disease
    N. Garcia, Maiken Mellergaard, H. González-King, C. Salomon, A. Handberg · 2023 · International Journal of Molecular Sciences
  49. Transforming Growth Factor β Acts as a Regulatory Molecule for Lipogenic Pathways among Hepatitis C Virus Genotype-Specific Infections
    Tapas Patra, Reina Sasaki, Keith Meyer, Ratna B. Ray, Ranjit Ray · 2019 · Journal of Virology
  50. Loss of ERdj5 exacerbates oxidative stress in mice with alcoholic liver disease via suppressing Nrf2
    Dong-Gyun Hong, Ga Yeon Song, Cheol Bin Eom, Jae-Hee Ahn, Sun Myoung Kim, Aeri Shim, Yong‐Hyun Han, Yoon‐Seok Roh, Chang Yeob Han, Eun Ju Bae et al. · 2022 · Free Radical Biology and Medicine
  51. Microarray analysis of differentially expressed genes and their functions in omental visceral adipose tissues of pregnant women with vs. without gestational diabetes mellitus
    Yuan Qian, Hao Xuan Sun, Hongli Xiao, Meirun Ma, Xue Xiao, Qinzai Qu · 2017 · Biomedical Reports
  52. Histological and biochemical evaluation of transforming growth factor-β activation and its clinical significance in patients with chronic liver disease
    Hiroshi Yokoyama, Takahiro Masaki, Ikuyo Inoue, Mariko Nakamura, Yoshihiro Mezaki, Chisato Saeki, Tsunekazu Oikawa, Masayuki Saruta, Hiroyuki Takahashi, Masahiro Ikegami et al. · 2019 · Heliyon
  53. Secretory IgA accumulated in the airspaces of idiopathic pulmonary fibrosis and promoted VEGF, TGF-β and IL-8 production by A549 cells
    Kimio Kobayashi, Maho Suzukawa, Kousuke Watanabe, Sayaka Arakawa, Sayaka Igarashi, Isao Asari, Akira Hebisawa, H Matsui, H Nagai, Takahide Nagase et al. · 2019 · Clinical & Experimental Immunology
  54. Hepatic regulator of G protein signaling 14 ameliorates NAFLD through activating cAMP-AMPK signaling by targeting Giα1/3
    Junyong Wang, Yaping Guo, Yunduan He, Yifan Qin, Xiuling Li, Ling Yang, Kangdong Liu, Xiao Li · 2024 · Molecular Metabolism
  55. Melatonin mitigated methotrexate-induced hepatotoxicity through interrelated biological processes
    Noura Abdallah, Maggie E. Amer, Maher A. Amer, Mohamed Amr El-Missiry, Azza I. Othman · 2024 · Molecular Biology Reports
  56. Variations in hepatic lipid species of age-matched male mice fed a methionine-choline-deficient diet and housed in different animal facilities
    Lisa Rein‐Fischboeck, Elisabeth M. Haberl, Rebekka Pohl, Susanne Feder, Gerhard Liebisch, Sabrina Krautbauer, Christa Buechler · 2019 · Lipids in Health and Disease
  57. Fetuin-A in newly detected type 2 diabetes mellitus as a marker of non-alcoholic fatty liver disease
    P Ganavi Yamasandhi, Mala Dharmalingam, Avinash Bhat Balekuduru · 2021 · Indian Journal of Gastroenterology
  58. Shenkang Injection for Treating Renal Fibrosis-Metabonomics and Regulation of E3 Ubiquitin Ligase Smurfs on TGF-β/Smads Signal Transduction
    Junju Zou, Xiaotao Zhou, Xian Chen, Yue‐Rong Ma, Rong Yu · 2022 · Frontiers in Pharmacology
  59. Exosome prospects in the diagnosis and treatment of non-alcoholic fatty liver disease
    Amirhossein Tamimi, Mona Javid, Nasrin Sedighi-Pirsaraei, Arian Mirdamadi · 2024 · Frontiers in Medicine
  60. Recent advances in targeting obesity, with a focus on TGF-β signaling and vagus nerve innervation
    Sahara John, Krishanu Bhowmick, ANDREW W. PARK, Hai Huang, Xiaochun Yang, Lopa Mishra · 2025 · Bioelectronic Medicine
  61. Trans-anethole attenuates diet-induced nonalcoholic steatohepatitis through suppressing TGF-β-mediated fibrosis
    Caicai Zhang, Baoyong Zhang, Aifang Chen, Qiling Yin, Haixia Wang · 2021 · Clinics and Research in Hepatology and Gastroenterology
  62. c‐Met Signaling Protects from Nonalcoholic Steatohepatitis‐ (NASH‐) Induced Fibrosis in Different Liver Cell Types
    Hannah K. Drescher, Fabienne Schumacher, Teresa Schenker, Maike Baues, Twan Lammers, Thomas Hieronymus, Christian Trautwein, Konrad L. Streetz, Daniela C. Kroy · 2018 · Oxidative Medicine and Cellular Longevity
  63. ATF4 drives regulatory T cell functional specification in homeostasis and obesity
    Ke Wang, Andrea Farrell, Enchen Zhou, Houji Qin, Zixuan Zeng, Kailun Zhou, Karina Cunha e Rocha, Dinghong Zhang, Gaowei Wang, Amha Atakilit et al. · 2025 · Science Immunology
  64. Effect of Human Umbilical Cord Mesenchymal Stem Cells Transfected with HGF on TGF-β1/Smad Signaling Pathway in Carbon Tetrachloride-Induced Liver Fibrosis Rats
    Fei Yin, Wenying Wang, Li-Cui Mao, Qi-Qi Cai, Wenhua Jiang · 2020 · Stem Cells and Development
  65. Tanshinone IIA Ameliorates Nonalcoholic Steatohepatitis in Mice by Modulating Neutrophil Extracellular Traps and Hepatocyte Apoptosis
    Lianjie Xu, Xiao Liu, Tao Jia, Yanhong Sun, Yan Du, Shanshan Wei, Wei Wang, Yurong Zhang, Wenhui Chen, Shan Zhang · 2022 · Evidence-based Complementary and Alternative Medicine
  66. Liver and systemic insulin resistance
    Nicolas Lanthier, Isabelle Anne Leclercq · 2014 · Hepatology
  67. TCDD dysregulation of lncRNA expression, liver zonation and intercellular communication across the liver lobule
    Kritika Karri, David J. Waxman · 2023 · Toxicology and Applied Pharmacology
  68. Developmental modeling of hepatogenesis using obese iPSCs-hepatocyte differentiation uncovers pathological features
    Divya Saro Varghese, Thilina T. Alawathugoda, Muhammad Abid Sheikh, Anil Kumar Challagandla, Bright Starling Emerald, Suraiya Anjum Ansari · 2022 · Cell Death and Disease
  69. Delineating tesamorelin response pathways in HIV-associated NAFLD using a targeted proteomic and transcriptomic approach
    Lindsay T. Fourman, Takara Leah Stanley, James M. Billingsley, Shannan J. Ho Sui, Meghan N. Feldpausch, Autumn Boutin, Isabel Zheng, Colin M. McClure, Kathleen E. Corey, Martin Torriani et al. · 2021 · Scientific Reports
  70. TGF Beta Induces Vitamin D Receptor and Modulates Mitochondrial Activity of Human Pancreatic Cancer Cells
    Camilla Fiz, Giulia Apprato, Chiara Ricca, Alessia Aillon, Loredana Bergandi, Francesca Silvagno · 2021 · Cancers
  71. Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial function
    Gretchen Wolff, Minako Sakurai, Amit Mhamane, Maria Troullinaki, Adriano Maida, Ioannis K. Deligiannis, Kelvin Yin, Peter Weber, Jakob Morgenstern, Annika Wieder et al. · 2022 · Molecular Metabolism
  72. Extracellular Vesicles from Escherichia coli Strains of the Gut Microbiota Trigger Hepatic Antioxidant and Anti-Lipogenic Effects via the Gut-Liver Axis in Healthy Neonatal Rats
    Sergio Martínez-Ruiz, Josefa Badı́a, Laura Baldomà · 2025 · Nutrients
  73. Downregulation of fatty acid oxidation led by Hilpda increases G2/M arrest/delay-induced kidney fibrosis
    Limin Liu, Ting Liu, Rui Jia, Lizi Zhang, Zijian Lv, Zhixiong He, Yishan Qu, Shiren Sun, Fadao Tai · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  74. New insights into therapeutic strategies for targeting hepatic macrophages to alleviate liver fibrosis
    Jialu Zhang, Zhaojing Xie, Xueyu Zhu, Chenxi Xu, Jiguo Lin, Mingqi Zhao, Yunyun Cheng · 2025 · International Immunopharmacology
  75. Extracellular vesicle-dependent crosstalk between hepatic stellate cells and Kupffer cells promotes their mutual activation
    Junyu Wang, Jia Li, Manon Buist‐Homan, Martin C. Harmsen, Han J. Moshage · 2025 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  76. Impaired reciprocal regulation between SIRT6 and TGF‐β signaling in fatty liver
    Xiyan Xiang, Kazufumi Ohshiro, Sobia Zaidi, Xiaochun Yang, Krishanu Bhowmick, Anil K. Vegesna, David Bernstein, James M. Crawford, Bibhuti Mishra, Patricia S. Latham et al. · 2022 · The FASEB Journal
  77. Inflammasome-Mediated Cytokines: A Key Connection between Obesity-Associated NASH and Liver Cancer Progression
    Nathalia Soares da Cruz, Gabriel Pasquarelli-do-Nascimento, Augusto Cézar Polveiro e Oliveira, Kelly Grace Magalhães · 2022 · Biomedicines
  78. Protective effect of rimonabant, a canabinoid receptor 1 antagonist, on nonalcoholic fatty liver disease in a rat model through modulation of the hepatic expression of activin A and follistatin
    Noha Ibrahim Hussien, Hanan Elkerdasy, Mohammad El-tantawy Ibrahim · 2017 · Canadian Journal of Physiology and Pharmacology
  79. Perturbation-Based Proteomic Correlation Profiling as a Target Deconvolution Methodology
    Yu Ohki, Hidetaka Sakurai, Madoka Hoshino, Hideki Terashima, Hiroki Shimizu, TOMIO ISHIKAWA, Tomoko Ogiyama, Yasunori Muramatsu, Toshiyuki Nakanishi, Shojiro Miyazaki et al. · 2018 · Cell chemical biology
  80. Transforming Growth Factor Beta Receptor 3 Haplotypes in Sickle Cell Disease Are Associated with Lipid Profile and Clinical Manifestations
    Rayra Pereira Santiago, Camylla V. B. Figueiredo, Luciana Magalhães Fiuza, Sètondji Cocou Modeste Alexandre Yahouédéhou, Rodrigo Mota de Oliveira, Milena Magalhães Aleluia, Suéllen Pinheiro Carvalho, Cleverson Alves Fonseca, Valma Maria Lopes Nascimento, Larissa Rocha et al. · 2020 · Mediators of Inflammation
  81. Transcription Factor Forkhead Box O1 Mediates Transforming Growth Factor-β1–Induced Apoptosis in Hepatocytes
    Yunmei Chen, Quan Pan, Wang Liao, Weiqi Ai, Sijun Yang, Shaodong Guo · 2023 · American Journal Of Pathology
  82. Transforming growth factor- β mediated regulation of epigenome is required for epithelial to mesenchymal transition associated features in liver cancer cells
    Abhilasha Srivastava, Harshita Sharma, Shibasish Chowdhury, Rajdeep Chowdhury, Sudeshna Mukherjee · 2023 · Heliyon
  83. The kielin/chordin-like protein KCP attenuates nonalcoholic fatty liver disease in mice
    Abdul A. Soofi, Katherine I. Wolf, Egon J. Ranghini, M. Asif Amin, Gregory R. Dressler · 2016 · American Journal of Physiology-Gastrointestinal and Liver Physiology
  84. Pharmacologic therapy for nonalcoholic steatohepatitis focusing on pathophysiology
    In Cheol Yoon, Jong Ryul Eun · 2019 · Journal of Yeungnam Medical Science
  85. In Utero One‐Carbon Metabolism Interplay and Metabolic Syndrome in Cardiovascular Disease Risk Reduction
    Lawrence Mabasa, Ebrahim Samodien, Nonhlakanipho Felicia Sangweni, Carmen Pheiffer, Johan Louw, Rabia Johnson · 2019 · Molecular Nutrition & Food Research
  86. Transforming growth factor‐beta 1: A new factor reducing hepatic SHBG production in liver fibrosis
    Laura Briansó‐Llort, Lidia Fuertes‐Rioja, Lorena Ramos‐Perez, María Teresa Salcedo, Cristina Hernández, Rafael Simó, David M. Selva · 2022 · Journal of Cellular Physiology
  87. RETRACTED ARTICLE: 1,25(OH)2D3 improves blood lipid metabolism, liver function, and atherosclerosis by constraining the TGF-β/Smad signaling pathway in rats with hyperlipidemia
    Chunpeng Lu, Yanping Yin, Yongliang Cui, Lili Wang, Yan Bai, Jian Li, Tingting Huang, Maimaiti Reziwanguli, Lifu Miao · 2019 · Cell Cycle · Retracted
  88. CREBH knockout accelerates hepatic fibrosis in mouse models of diet-induced nonalcoholic fatty liver disease
    Guixin Li, Junli Zhang, Qianqian Jiang, Beibei Liu, Keshu Xu · 2020 · Life Sciences
  89. Pharmacological systemic analysis of gardenia fructus against non-alcoholic fatty liver disease and validation of animal models
    Kang Pa Lee, Ki Bong Kim, Eunhee Yoon, Suji Baek, Sang Hyun Ahn · 2022 · Physical Activity and Nutrition
  90. The Effect of Curcumin on Regression of Liver Fibrosis through Decreased Expression of Transforming Growth Factor-β1 (TGF-β1)
    Supriono Supriono, Asri Nugraheni, Handono Kalim, Mudjiwijono Handaru Eko · 2019 · The Indonesian Biomedical Journal
  91. Integrated lipidomic and transcriptomics to explore the effects of ethyl acetate extract of Herpetospermum pedunculosum on nonalcoholic fatty liver disease in mice
    Boyu Zhang, Cairong Han, Zhongrui Zhang, Akida Adiham, Rui Tan, Puyang Gong, Jian Gu · 2024 · Journal of Ethnopharmacology
  92. Pirfenidone ameliorates liver steatosis by targeting the STAT3-SCD1 axis
    Shan Yang, Renzi Zhang, Wenzhen Deng, Shi-Chuan Chang, Yang Li, Sheng Li · 2023 · Inflammation Research
  93. miR-12135 ameliorates liver fibrosis accompanied with the downregulation of integrin subunit alpha 11
    Motofumi Kumazoe, Emi Miyamoto, Chihiro Oka, Miyuki Kondo, Ren Yoshitomi, Hiroaki Onda, Yu Shimada, Yoshinori Fujimura, Hirofumi Tachibana · 2023 · iScience
  94. Cerium oxide nanoparticles modulate liver X receptor and short heterodimer partner, and attenuate liver steatosis and steatohepatitis in a rat model of postmenopausal obesity
    Fatma Lebda, Sahar Mohamed El Agaty, Radwa Hassan Ali, Ghada Galal Hamam, Aliaa M. Abd, Noha N. Lasheen · 2022 · General Physiology and Biophysics
  95. Transforming Growth Factor-β Signaling in Alcohol-Associated Liver Disease
    Huihui Zou, Sai Wang, Chenjun Huang, Steven Dooley, Nadja M. Meindl‐Beinker · 2025 · American Journal Of Pathology
  96. Endocrine and metabolic drivers of sebum dysregulation: Mechanisms and therapeutic strategies
    Jie Li, Bingyong Mao, Xin Tang, Qiuxiang Zhang, Jianxin Zhao, Hao Zhang, Wei Chen, Shumao Cui · 2025 · Life Sciences
  97. Quercetin prevents rats from type 1 diabetic liver damage by inhibiting TGF-ꞵ/apelin gene expression
    Firouzeh Gholampour, A. Jones Susan, Zeinab Karimi · 2024 · Current Research in Pharmacology and Drug Discovery
  98. Activation of TAF9 via Danshensu-Induced Upregulation of HDAC1 Expression Alleviates Non-alcoholic Fatty Liver Disease
    Ruiwen Wang, Zhecheng Wang, Ruimin Sun, Rong Fu, Yu Sun, Meiyang Zhu, Yunfei Geng, Dongyan Gao, Xiaofeng Tian, Yan Zhao et al. · 2021 · Frontiers in Pharmacology
  99. Spatiotemporal expression of matrix metalloproteinase-1 in progression of nonalcoholic steatohepatitis
    Hiroaki Yokomori, Yutaka Inagaki, Wataru Ando, Hara M, Komiyama T, Shun Kojima, Oda M, Kuroda H, Yutaka Suzuki, Isao Okazaki · 2016 · Journal of Modern Human Pathology
  100. Mechanisms Associated with the Effect of Hypericum perforatum and Smilax cordifolia Aqueous Extracts on Hepatic Steatosis in Obese Rats: A Lipidomic Approach
    Iza Fernanda Pérez‐Ramírez, Marco A. Gallegos‐Corona, Laura González‐Dávalos, Ofelia Mora, Nuria Elizabeth Rocha‐Guzmán, Rosalía Reynoso‐Camacho · 2018 · European Journal of Lipid Science and Technology